Contract Manufacturing

Yseop's impactful Generative AI capabilities helping accelerate drugs to market

07-Dec-2023 By Liza Laws

Today, world-leading generative artificial intelligence (AI) company for life sciences, Yseop, is celebrating its involvement in more than 150 clinical trials with pharma giants around the world.

ObvioHealth reveals new digital therapeutics API to capture more accurate clinical data

07-Dec-2023 By Liza Laws

Virtual research organization, ObvioHealth, has just announced the launch of its application programming interface (API) which it says is tailored specifically for digital therapeutics (DTx) clinical trials.

Piramal Pharma has launched a high-throughput screening facility

06-Dec-2023 By Liza Laws

Piramal Pharma has launched a high-throughput screening facility at its drug discovery services site in Ahmedabad, India.

Hilleman Laboratories unveils $20 million Singapore facility to boost vaccine manufacturing

28-Nov-2023 By Isabel Cameron

Hilleman Laboratories has opened a new 30,000 sq ft manufacturing facility in Singapore.

CluePoints wins prestigious accolade for commitment to innovation and education

21-Nov-2023 By Liza Laws

CluePoints, a company providing risk-based study execution (RBx) and risk-based quality management (RBQM) software for clinical trials has won the best Contract Research Organization (CRO) in the specialist providers category at Citeline’s 2023 SCRIP...

Interview: CRO PPD of Thermo Fisher - the processes and difficulties within rare diseases

17-Nov-2023 By Liza Laws

OSP was delighted to speak to Galina Nesterova, executive medical director at the Rare Disease & Pediatrics Center of Excellence, and Susan McCune, vice president of pediatrics and clinical pharmacology both within medical science and strategy at...

Prange Group and Adragos Pharma to acquire Fresenius Kabi’s Norwegian manufacturing site

17-Nov-2023 By Liza Laws

Definitive agreements with Fresenius Kabi have been signed by Prange Group and its affiliate Adragos Pharma for its sterile pharmaceutical production site in Halden, Norway.

Dpharm Deep Dive: Speeding up access to clinical data and how picking EDETEK was a good choice for Pfizer

17-Nov-2023 By Liza Laws

EDETEK and Pfizer are in collaboration to speed access to clinical data, promote interoperability and enable data visualization to drive faster decision-making capabilities in clinical operations.

Medidata recommits to Catalyst Clinical Research expanding multi-year partnership

06-Nov-2023 By Liza Laws

Medidata has recommitted to Catalyst Clinical Research to support its worldwide oncology brand, Catalyst Oncology.

Women in Science: Kathryn Starzyk on the power and complexities of real-world evidence

01-Nov-2023 By Liza Laws

Kathryn Starzyk is an epidemiologist and currently vice president of real-world evidence (RWE) at healthcare technology company, OM1.

M&G’s Catalyst invests $57 million with SkyCell to improve transportation of temperature-controlled medicines

31-Oct-2023 By Liza Laws

M&G Investments has made a $57 million investment with Swiss-based tech firm, SkyCell and says it is seeking to change the face of international pharma supply chains.

AxoSim's acquisition of microBrain to transform neurological R&D

24-Oct-2023 By Liza Laws

A company’s goal of delivering human data faster to ‘transform neurological R&D’ has been boosted by the completion of an acquisition.

Empatica and the importance of wearable devices in getting the full patient profile

20-Oct-2023 By Liza Laws

Matteo Lai was part of a panel at DPharm in Boston this year, it was called working together to accelerate the adoption of digital biomarkers in clinical trials.

Interview: EDETEK's Munther Baara on the paradigm shift in clinical trials

12-Oct-2023 By Liza Laws

Munther Baara has worked in the life sciences arena for more than 30 years. He has always been completely committed.

H1 launches new AI tool with 'power to be pharma's most impactful LLM'

09-Oct-2023 By Liza Laws

A new generative artificial intelligence (AI) tool has been launched by H1, a global healthcare data company and will have a 'profound impact on clinical trial diversity'.

NCI and Medidata extend partnership by five years to support critical oncology research

09-Oct-2023 By Liza Laws

A 15-year partnership between Medidata, a Dassault Systèmes company, and the National Cancer Institute (NCI) has been extended by five years. The NCI is part of the National Institutes of Health.

Lokavant receives $8 million from investment giant, Mitsui to expand AI platform

05-Oct-2023 By Liza Laws

Clinical trial platform company, Lokavant, has received an $8 million strategic investment from global trading and investment giant, Mitsui & Co. Ltd.

Interview: Andrew MacGarvey COO of Phastar on opportunities for big analytical data

04-Sep-2023 By Liza Laws

Andrew MacGarvey is chief operating officer (COO) of Phastar. We caught up with him earlier in the summer at DIA Global in Boston to discuss the company’s origins, opportunities for big analytical data DCTs, artificial intelligence and machine learning...

H.E.L Group makes the move to bigger and better premises with a focus on innovation and collaboration

20-Jun-2023 By Liza Laws

Developer and manufacturer of innovative laboratory tools, H.E.L Group has announced today (June 20) it is expanding into a 16,000 sq. ft new site.

Wheeler Bio welcomes Charles River's flexible testing lab to Oklahoma site

01-Jun-2023 By Liza Laws

CDMO Wheeler Bio, Inc. has welcomed Charles River’s flexible biologics testing lab, RightSource, to its Oklahoma City drug substance manufacturing site.

ClinOne closes $3M series A funding and welcomes new board memeber

18-Apr-2023 By Liza Laws

A company providing a single platform to support clients’ clinical trial journeys has closed a $3 million Series A funding.

Investment firm launches CDMO after Pfizer facility buyout

11-Apr-2023 By Ben Hargreaves

Bridgewest launches a new CDMO that will be branded NovaCina, operating out of Australia and specializing in sterile injectable drug products.

Operio makes manufacturing acquisition with European expansion aim

11-Apr-2023 By Ben Hargreaves

Operio has acquired a group of companies that provide both manufacturing equipment and services in the solid dose space.

Hovione and Laxxon partner on 3D printed pharmaceuticals

27-Mar-2023 By Ben Hargreaves

The two companies enter into a long-term partnership to advance 3D screen printing technologies for applications within the pharma industry.

Zebra adds new environmental sensors for pharma supply chain

23-Mar-2023 By Ben Hargreaves

The company launches its new ZS300 sensor, ZB200 bridge and Android sensor discovery app, which will be made available for use with the supply chains of the pharma and food industries.

CatSci Ltd and AGC Pharma Chemicals announce their strategic partnership

16-Mar-2023 By Liza Laws

Medicine developer, CatSci Ltd announced yesterday (March 15) that it has formed a new partnership with AGC Pharma Chemicals, a small molecule Contract Development and Manufacturing Organisation (CDMO).

Genixus adds manufacturing facility for syringe production

16-Mar-2023 By Ben Hargreaves

The company will build out a manufacturing, warehousing, and distribution center in the US to expand capacity for syringes.

LG Chem targets becoming top 20 oncology company

14-Mar-2023 By Ben Hargreaves

After completing the acquisition of Aveo, the Korean chemical company wants its subsidiary to become a global leader in the therapeutic area within five years.

Piramal begins production at API facility in Michigan

20-Feb-2023 By Ben Hargreaves

The Indian company begins production of APIs and HPAPIs, after expanding capacity at its Riverview site.

AZ blames UK tax for Ireland API plant decision

13-Feb-2023 By Ben Hargreaves

The company’s CEO stated that a ‘discouraging tax rate’ was behind the decision to build a $360m API plant in Ireland rather than the UK.

WuXi opens continuous manufacturing line for oral solids

09-Jan-2023 By Ben Hargreaves

The CDMO announces the launch of its first drug product continuous manufacturing line for oral solids, located in Wuxi City, China.

Soaring process development revenues prompt Avid to raise full-year guidance

15-Dec-2022 By Nick Taylor

Avid Bioservices has raised its full-year revenue guidance after process development sales hit a new high in its latest quarterly financial results.

API CDMO joins SBTi to reduce carbon footprint 'at every level'

08-Dec-2022 By Maggie Lynch

CordenPharma joins global science initiative SBTi and announces commitment to ambitious reduction in greenhouse gas emissions in alignment with the Paris agreement.

CPI and 24 partners open £88m manufacturing innovation center

06-Dec-2022 By Ben Hargreaves

The collaborators unveil the facility after combing ideas from pharma and technology sectors to develop more sustainable manufacturing processes.

‘A win-win situation’: Terumo CDMO invests in parenteral drug services

07-Nov-2022 By Maggie Lynch

Japanese CDMO expands services to meet demand for parenteral drugs for global customers.

Charles River wins gene therapy manufacturing contract from Nanoscope

07-Nov-2022 By Nick Taylor

Charles River Laboratories’ growing gene therapy manufacturing capabilities have landed it a deal with the eye disease biotech Nanoscope Therapeutics.

Corium sells off CDMO business for $400m

27-Oct-2022 By Ben Hargreaves

The company will split into two separate entities, one will focus on the development of neuroscience therapies and the other will become a standalone CDMO.

‘Innovators need to meet contract services partners sooner, plan much earlier and far further into development’

26-Oct-2022 By Rachel Arthur

A ‘significant shift’ is under way in global outsourcing strategies: with the sector moving away from phase-appropriate development in favor of a more forward-looking model – with experts advising starting the search for an outsourcing partner as early...

CPHI Pharma Award finalists announced

26-Oct-2022

The awards cover innovations spanning the full pharmaceutical supply chain and feature many of pharma’s biggest names and breakthrough companies.

Adragos snaps up Sanofi’s Japanese manufacturing facility

24-Oct-2022 By Ben Hargreaves

The German CDMO signs an agreement to acquire Sanofi’s Kawagoe-based facility, which adds to the company’s existing presence in the country.

WuXi fills ‘capacity gap’ with HP facility in Wuxi city

04-Oct-2022 By Maggie Lynch

WuXi STA continues its growth and opens its first high potency oral drug product manufacturing facility at its Wuxi city campus.

People on the Move: September 2022

01-Sep-2022 By Jenni Spinner

This month’s announcements of appointments, acquisitions, new hires, and other news include Standigm, Astellas Pharma, Trialbee, and other key companies.

Lonza expanding dry powder inhalation capabilities at Florida site

01-Sep-2022 By Jenni Spinner

In response to rising demand for inhalable treatments geard toward respiratory conditions, the company is adding capabilities and capacity at its Tampa site.

Market demands, trends impacting APIs and excipients: MilliporeSigma

31-Aug-2022 By Jenni Spinner

An expert from the company discusses how ever-changing patient needs and other dynamic factors are likely to impact pharma ingredient trends down the road.

New WuXi STA plant to tackle growing HPAPI demand

31-Aug-2022 By Jenni Spinner

A company leader advises that the growing need for high-potency active pharmaceutical ingredients calls for CDMOs that consistently deliver quality at scale.

Cutting ‘pain points’ can streamline chemical reporting: ACD/Labs

30-Aug-2022 By Jenni Spinner

A representative from the R&D tech provider offers advice on how to wrangle with a stressful, complicated process for better results and fewer headaches.

Charles River opens research facilities in California and Washington

30-Aug-2022 By Jane Byrne

Organization extends turnkey research facility network to San Diego, San Francisco, Thousand Oaks, and Seattle.

Outsourcing strategists thinking farther ahead than ever: CPHI

23-Aug-2022 By Jenni Spinner

The group’s latest report glimpses inside the minds of pharma leaders, who are looking at a product’s full life-cycle development at the preclinical stage.

Tech Innovations: August 2022

22-Aug-2022 By Jenni Spinner

This month’s news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.

UPS acquires multi-national healthcare logistics company Bomi

15-Aug-2022 By Jenni Spinner

The purchase brings under the UPS Healthcare umbrella several temperature-controlled facilities in 14 countries situated throughout Europe and Latin America.

Product Innovations

Generic method approach for determination of residual solvents in active pharmaceutical ingredients by gas chromatography

Solvents are defined as organic chemicals that are used to dissolve components. They are used during the manufacture of drug substances and can also potentially...

Pulmonary Delivery of Orally Inhaled Therapeutics

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Addressing Challenges with Clinical In-Use Testing

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

Outsourcing-Pharma

Resources